Search for: "Nicholson Price"
Results 121 - 140
of 152
Sorted by Relevance
|
Sort by Date
30 Jul 2021, 5:03 am
By Nicholson Price, Rachel Sachs, Jacob S. [read post]
24 Jun 2020, 5:36 pm
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
21 Jan 2022, 8:35 am
But garnering enough—at reasonable prices—is often difficult for even the simplest analyses, and a point of antitrust scrutiny. [read post]
8 Jun 2022, 5:23 am
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
2 Jun 2020, 10:31 pm
By Nicholson Price, Rachel Sachs, Jacob S. [read post]
12 Jan 2021, 9:04 am
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
5 Aug 2020, 11:43 am
By Nicholson Price, Rachel Sachs, Jacob S. [read post]
30 Jun 2021, 10:31 am
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
30 Mar 2020, 8:40 am
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob SherkowOne of the dizzying stream of innovation and health law stories to emerge last week is Oracle’s partnership with the White House to study unproven pharmaceuticals for treating COVID-19. [read post]
25 Mar 2021, 1:24 pm
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
22 Jul 2020, 12:12 pm
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsOver 120 years ago, a milk wagon horse named Jim was the United States’ most potent weapon against a raging diphtheria epidemic. [read post]
10 Jul 2020, 8:59 am
Sherkow, Lisa Larrimore Ouellette, and Nicholson PricePolicymakers are expectantly awaiting the development of a COVID-19 vaccine, which they view as critical to future management of the pandemic. [read post]
3 Aug 2023, 8:15 am
Matthew Sag, Copyright Safety for Generative AI Not addressing whether training is always fair use in every circumstance; explain how generative AI fits w/in existing law (nonexpressive uses) and identify best practices to make generative AI fairer. [read post]
5 Nov 2021, 8:20 am
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
Why is HHS blocking FDA from regulating some diagnostics, and how will this affect COVID-19 testing?
25 Aug 2020, 4:50 pm
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
15 Apr 2020, 8:14 am
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob SherkowIt’s now clear that expansive, population-wide testing is part-and-parcel of every successful COVID-19 containment strategy. [read post]
29 May 2024, 3:52 pm
They confirm how “socioeconomic status impacts judicial outcomes and how low- to middle-income people are priced out of the fairness touted by our system. [read post]
11 Aug 2021, 3:21 pm
Nicholson Price: Is there a theory justifying the use of multiple hypothesis testing? [read post]
30 Jul 2018, 10:44 am
(Related to literature on basing damages on R&D costs, which I review here.)Nicholson Price – The novelty requirement is not always aligned with social welfare, as illustrated by the biomedical field. [read post]
10 Oct 2009, 5:55 am
Price Foundation (WAPF). [read post]
